Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogen Sulfide | 12 | 2023 | 77 | 2.180 |
Why?
|
| Ciliary Arteries | 5 | 2025 | 10 | 1.930 |
Why?
|
| Aqueous Humor | 6 | 2017 | 18 | 1.920 |
Why?
|
| Retina | 8 | 2025 | 289 | 1.430 |
Why?
|
| Cysteine | 7 | 2019 | 103 | 1.090 |
Why?
|
| Receptors, Bradykinin | 1 | 2025 | 2 | 0.950 |
Why?
|
| Vasoconstriction | 1 | 2025 | 42 | 0.930 |
Why?
|
| Muscle Contraction | 4 | 2025 | 67 | 0.920 |
Why?
|
| Sulfides | 6 | 2023 | 78 | 0.740 |
Why?
|
| Ophthalmic Solutions | 2 | 2017 | 18 | 0.680 |
Why?
|
| Serotonin Antagonists | 2 | 2018 | 22 | 0.680 |
Why?
|
| Cattle | 13 | 2025 | 498 | 0.680 |
Why?
|
| Trabecular Meshwork | 4 | 2008 | 10 | 0.660 |
Why?
|
| Cyclic AMP | 2 | 2012 | 127 | 0.650 |
Why?
|
| Anterior Eye Segment | 2 | 2017 | 9 | 0.590 |
Why?
|
| Muscle Relaxation | 3 | 2025 | 19 | 0.590 |
Why?
|
| Arachidonic Acids | 2 | 2008 | 25 | 0.560 |
Why?
|
| Ophthalmic Artery | 1 | 2018 | 4 | 0.560 |
Why?
|
| Glycerides | 2 | 2008 | 12 | 0.530 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2025 | 1124 | 0.520 |
Why?
|
| Glaucoma | 2 | 2017 | 100 | 0.520 |
Why?
|
| Swine | 9 | 2023 | 212 | 0.490 |
Why?
|
| Ciliary Body | 4 | 2025 | 14 | 0.480 |
Why?
|
| Iris | 3 | 2010 | 11 | 0.470 |
Why?
|
| Intraocular Pressure | 3 | 2025 | 132 | 0.460 |
Why?
|
| Animals | 26 | 2025 | 16992 | 0.460 |
Why?
|
| Muscle, Smooth | 2 | 2025 | 58 | 0.380 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2012 | 31 | 0.360 |
Why?
|
| Receptor, Cannabinoid, CB1 | 2 | 2008 | 41 | 0.310 |
Why?
|
| Piperidines | 4 | 2015 | 83 | 0.300 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2008 | 15 | 0.290 |
Why?
|
| Air Pollutants | 1 | 2009 | 130 | 0.280 |
Why?
|
| Cystathionine gamma-Lyase | 6 | 2015 | 15 | 0.260 |
Why?
|
| Organothiophosphorus Compounds | 3 | 2016 | 8 | 0.260 |
Why?
|
| Morpholines | 3 | 2016 | 72 | 0.250 |
Why?
|
| Cystathionine beta-Synthase | 5 | 2015 | 16 | 0.240 |
Why?
|
| Kinins | 1 | 2025 | 5 | 0.240 |
Why?
|
| Bradykinin | 1 | 2025 | 25 | 0.240 |
Why?
|
| Organ Culture Techniques | 5 | 2008 | 101 | 0.230 |
Why?
|
| KATP Channels | 4 | 2015 | 10 | 0.220 |
Why?
|
| Pyrazoles | 4 | 2008 | 103 | 0.210 |
Why?
|
| Phenylephrine | 3 | 2025 | 34 | 0.190 |
Why?
|
| Peptides | 1 | 2025 | 372 | 0.190 |
Why?
|
| Neurons | 1 | 2009 | 1263 | 0.180 |
Why?
|
| Sympathetic Nervous System | 2 | 2015 | 57 | 0.180 |
Why?
|
| D-Aspartic Acid | 2 | 2011 | 8 | 0.170 |
Why?
|
| Carbachol | 3 | 2025 | 18 | 0.160 |
Why?
|
| Prostaglandins F, Synthetic | 2 | 2016 | 6 | 0.150 |
Why?
|
| Thioctic Acid | 2 | 2016 | 16 | 0.150 |
Why?
|
| Lens, Crystalline | 1 | 2019 | 39 | 0.150 |
Why?
|
| Cataract | 1 | 2019 | 47 | 0.140 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2018 | 5 | 0.140 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2018 | 7 | 0.140 |
Why?
|
| Excitatory Amino Acids | 1 | 2017 | 7 | 0.140 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 87 | 0.140 |
Why?
|
| Endocannabinoids | 2 | 2008 | 41 | 0.140 |
Why?
|
| Enzyme Inhibitors | 3 | 2015 | 458 | 0.140 |
Why?
|
| Receptors, Serotonin | 1 | 2018 | 23 | 0.140 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2008 | 38 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2008 | 883 | 0.120 |
Why?
|
| Flavonoids | 2 | 2008 | 100 | 0.120 |
Why?
|
| Prostaglandins | 2 | 2015 | 23 | 0.120 |
Why?
|
| Uvea | 1 | 2015 | 3 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2012 | 1621 | 0.110 |
Why?
|
| Pyrrolidines | 1 | 2015 | 31 | 0.110 |
Why?
|
| Organophosphorus Compounds | 1 | 2015 | 37 | 0.110 |
Why?
|
| Isoprostanes | 1 | 2014 | 13 | 0.110 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 269 | 0.110 |
Why?
|
| Alkynes | 2 | 2012 | 52 | 0.110 |
Why?
|
| Glycine | 2 | 2012 | 47 | 0.110 |
Why?
|
| Isometric Contraction | 2 | 2015 | 25 | 0.110 |
Why?
|
| Aspartic Acid | 1 | 2014 | 51 | 0.110 |
Why?
|
| Blood Pressure | 1 | 2018 | 666 | 0.110 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 140 | 0.100 |
Why?
|
| Vasodilation | 1 | 2013 | 64 | 0.100 |
Why?
|
| Receptors, Muscarinic | 2 | 2010 | 16 | 0.100 |
Why?
|
| Neurotransmitter Agents | 2 | 2011 | 69 | 0.090 |
Why?
|
| Aminooxyacetic Acid | 1 | 2012 | 3 | 0.090 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2012 | 28 | 0.090 |
Why?
|
| F2-Isoprostanes | 1 | 2011 | 18 | 0.090 |
Why?
|
| Sus scrofa | 2 | 2008 | 19 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2012 | 462 | 0.080 |
Why?
|
| Eye | 1 | 2011 | 77 | 0.080 |
Why?
|
| Cholinergic Agonists | 1 | 2010 | 6 | 0.080 |
Why?
|
| Glyburide | 1 | 2010 | 9 | 0.080 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2009 | 5 | 0.080 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2009 | 14 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2009 | 33 | 0.080 |
Why?
|
| Muscarinic Antagonists | 1 | 2008 | 11 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 108 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2006 | 105 | 0.070 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2008 | 2 | 0.070 |
Why?
|
| Amidohydrolases | 1 | 2008 | 12 | 0.070 |
Why?
|
| Chromatography, Thin Layer | 1 | 2008 | 39 | 0.070 |
Why?
|
| Carbamates | 1 | 2008 | 13 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 256 | 0.070 |
Why?
|
| Receptors, Cannabinoid | 1 | 2008 | 31 | 0.070 |
Why?
|
| Catecholamines | 1 | 2008 | 45 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2008 | 41 | 0.070 |
Why?
|
| Cytoskeleton | 1 | 2008 | 114 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2008 | 2157 | 0.070 |
Why?
|
| Benzamides | 1 | 2008 | 81 | 0.070 |
Why?
|
| Perfusion | 1 | 2006 | 38 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2006 | 51 | 0.060 |
Why?
|
| Regional Blood Flow | 1 | 2025 | 53 | 0.060 |
Why?
|
| Actins | 1 | 2006 | 164 | 0.060 |
Why?
|
| Vasoconstrictor Agents | 2 | 2015 | 39 | 0.050 |
Why?
|
| Rats | 1 | 2012 | 3735 | 0.050 |
Why?
|
| Indoles | 1 | 2005 | 187 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2006 | 986 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 182 | 0.050 |
Why?
|
| Norepinephrine | 2 | 2015 | 97 | 0.050 |
Why?
|
| Electric Stimulation | 2 | 2015 | 186 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2023 | 465 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 241 | 0.040 |
Why?
|
| Tritium | 2 | 2011 | 46 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 1081 | 0.040 |
Why?
|
| Reference Standards | 1 | 2019 | 55 | 0.040 |
Why?
|
| Nitric Oxide | 2 | 2015 | 386 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 158 | 0.040 |
Why?
|
| Glutathione | 1 | 2019 | 171 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 190 | 0.040 |
Why?
|
| Retinal Diseases | 1 | 2017 | 20 | 0.030 |
Why?
|
| Humans | 2 | 2017 | 43102 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 278 | 0.030 |
Why?
|
| Antioxidants | 1 | 2019 | 443 | 0.030 |
Why?
|
| Software Design | 1 | 2015 | 18 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 149 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2013 | 74 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1003 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2009 | 24 | 0.020 |
Why?
|
| Miotics | 1 | 2008 | 2 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 152 | 0.010 |
Why?
|
| Male | 1 | 2016 | 23409 | 0.010 |
Why?
|